1. Introduction {#sec1-toxics-08-00028}
===============

Acute poisonings are adverse health effects due to acute exposure (less than 24 hours) to a toxic substance, medications, drug overdose, acute drug abuse problems, chemical exposure, occupational and environmental toxins, biological agents, and envenomations \[[@B1-toxics-08-00028],[@B2-toxics-08-00028]\]. Intoxications are major public and preventable health issues, which are a frequent reason for the consultation of emergency rooms \[[@B3-toxics-08-00028],[@B4-toxics-08-00028]\] and typically represent 1--3% of all emergency department (ED) visits. Severe forms needing admission to intensive care units (ICUs) account for four and up to 40% of cases \[[@B5-toxics-08-00028],[@B6-toxics-08-00028],[@B7-toxics-08-00028]\] with a mortality rate of 3 to 6% \[[@B2-toxics-08-00028],[@B8-toxics-08-00028],[@B9-toxics-08-00028],[@B10-toxics-08-00028],[@B11-toxics-08-00028],[@B12-toxics-08-00028]\].

Therapeutic drug intoxication and, in many countries, chemical products such as pesticides remain a common cause for consultation in the ED and a significant cause for ICU admissions and fatalities. Indeed, severe cases with life-threatening conditions needing technical support or requiring constant monitoring are usually hospitalized in the ICU. Furthermore, the management of acute poisonings includes examining the mental health and social issues that lead to severe poisoning to help reduce the recurrence and poisoning fatality rates.

The toxic agents and the pattern of acute poisoning vary between centers in various countries that can change over time. Therefore, there is a constant need to obtain up-to-date information on acute poisoning for planning the rational use of resources and evaluating public health interventions. In most developed countries, anti-poison centers are available 24 h to record information and to provide specific and appropriate toxicological advice to manage poisoned patients. The epidemiologic data obtained permits a survey of the main trends of poisonings and the toxins used and to implement preventive actions. Thus, in metropolitan France, the epidemiology of acute poisonings is subject to frequent updates from the registries of the anti-poisons and toxicovigilance centers. For the first time, in 2006, 197,042 cases of human exposure have been analyzed and published \[[@B13-toxics-08-00028]\]. Interestingly, the vast majority (82.5%) of poison exposure was unintentional. In Martinique, however, a comparable database is sorely lacking. Few scientific data are therefore available about the characteristics of acute poisonings in the Caribbean region.

The aim of this study was to describe the clinical and sociodemographic patterns of acute poisonings in the EDs of the three main hospitals of Martinique (University Hospital of Martinique, and the general hospitals of Trinité and Lamentin).

2. Methods {#sec2-toxics-08-00028}
==========

Our study was retrospective and multicentric. It was conducted over 11 years from January 2000 to December 2010 in the three main hospitals of Martinique (University Hospital of Martinique and the general hospitals of Trinité and Lamentin), according to the Helsinki principles and it was declared to our national database review board (N°: 2216995 v 0).

Martinique is an overseas, insular region of France located in the Lesser Antilles of the West Indies in the eastern Caribbean Sea. One of the Windward Islands, it is directly north of Saint Lucia, northwest of Barbados and south of Dominica. The land area is about 1128 square kilometers and the population size is 376,480 inhabitants as of January 2016.

We included all patients aged more than eighteen years old presenting with severe poisoning. We excluded all patients less than eighteen, those presenting following envenomation by animal bites and stings, and those whose records were missing or did not provide sufficient data for the analysis. All patients admitted to the University Hospital of Martinique, the general hospital of Trinité, or the general hospital of Lamentin, whose primary or secondary diagnosis was acute poisoning, were initially selected from the archives of the Department of Medical Information (DIM) of these three hospitals. The selection of charts was based on the 10^th^ revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10). The codes used were poisoning by adverse effect of and underdosing of drugs, medicaments, and biological substances (T36-T50) and toxic effects of substances chiefly nonmedicinal as to source (T51--T65). Only charts with severe acute poisoning were studied. We recorded epidemiological and clinical data including age and sex of the patients, the date and time of the poisoning, the toxic substance, the type of exposure, and the clinical and biological parameters at admission to the ED.

Acute poisoning is defined as adverse health effects due to acute exposure (less than 24 hours) to a toxic substance, medications, drug overdose, acute drug abuse problems, chemical exposures, occupational and environmental toxins, biological agents, and envenomings \[[@B1-toxics-08-00028],[@B2-toxics-08-00028]\]. Severe acute intoxication is defined as an acute poisoning requiring technical support or close surveillance \[[@B1-toxics-08-00028]\].

Toxic agents were classified as therapeutic drugs and chemical drugs. The subgroup of toxic agents was categorized based on the indications for use. Multiple drugs were defined as the ingestion of two or more drugs. The type of exposure was classified as intentional self-poisoning, overdosage, accidental, or unknown \[[@B14-toxics-08-00028]\]. Severity at admission to ICU was assessed using the Simplified Acute Physiology Score (SAPS II) \[[@B15-toxics-08-00028]\] and the severity of the poisoning was assessed using the Poisoning Severity Score (PSS) \[[@B16-toxics-08-00028]\].

3. Statistical Analysis {#sec3-toxics-08-00028}
=======================

Results were reported as mean ± standard deviation or numbers with percentages. Bivariate statistical comparisons were conducted using the Chi-square or Fisher's exact test for categorical data and the Independent-Samples T-test for continuous data. Non-redundant variables selected by bivariate analysis (*p* \< 0.05) and considered clinically relevant were entered into a logistic regression model. Results were expressed as odds ratios (OR) with their 95% confidence intervals (CI). A *p*-value \< 0.05 was considered statistically significant.

Receiver operating characteristic (ROC) curves were used to evaluate the diagnostic value of quantitative tests. The area under the curve was estimated by the method of Hanley and McNeill \[[@B17-toxics-08-00028]\]. All statistical analyses were carried out with Excel (2010 Microsoft corporation, Redmond, USA) and IBM SPSS Statistics for Windows, version 24 (IBM Corp., Armonk, NY, USA, 2018).

4. Results {#sec4-toxics-08-00028}
==========

During the study period, 291 patients were admitted for severe poisoning, giving an incidence rate of 7.7 severe cases/100,000 inhabitants. The mean age was 46 ± 19 years and 166 (57%) were males. A history of psychiatric disorders was recorded in 143 (49.8%) patients. SAPS II at admission was 39 ± 23 points and PSS was 3 ± 1 points. Thirty patients (10.3%) died, and hospital length of stay was 6 ± 7 days. [Table 1](#toxics-08-00028-t001){ref-type="table"} reports the epidemiological characteristics and outcomes of these patients.

The mode of intoxication was intentional self-poisoning in 250 (86.5%) cases. The toxic agent involved was a therapeutic drug in 169 (58.1%) cases and a chemical product in 152 (52.2%) cases. A multiple therapeutic drugs intoxication was recorded in 61 (36.1%) cases, a multiple chemical intoxication was recorded in 48 (31.6%) cases, and a mixed therapeutic and chemical toxic was recorded in 30 cases (10.3%). Drug overdose was recorded in 37 (12.7%) cases. The most involved therapeutic drugs were psychotropic drugs (116 cases), benzodiazepines (76 cases), neuroleptics (33 cases), cardiotrops (26 cases), and tricyclic antidepressants (18 cases). The most involved chemical toxics were OH3 (56 cases), herbicide (29 cases), Rubigine^®^ (28 cases), caustics and Aldicarb (23 cases each) ([Figure 1](#toxics-08-00028-f001){ref-type="fig"}). [Table 2](#toxics-08-00028-t002){ref-type="table"} compares the survivors and non-survivors in relation to the various toxic substances used.

Clinical manifestations dominated by respiratory failure in 171 (58.8%) patients, hemodynamic failure in 78 (26.8%) patients, neurologic failure in 130 (44.7%) patients, gastrointestinal manifestations in 78 (26.8%) patients, and renal failure in 32 (11%) patients. The mean age was 56 ± 18 years in non survivors and 45 ± 18 years in survivors (*p* = 0.001). [Figure 2](#toxics-08-00028-f002){ref-type="fig"} shows the mortality rate according to age range and [Figure 3](#toxics-08-00028-f003){ref-type="fig"} shows the accuracy of age to predict death in poisoned patients. Polypnea, shock, ventricular fibrillation or tachycardia, and gastro-intestinal disorders are the main symptoms associated with death. The main biological abnormalities associated with death in our patients were metabolic acidosis, hypokalemia, hyperlactatemia, hypocalcemia, renal injury, rhabdomyolysis, increased aspartate aminotransferases, and thrombocytopenia. [Table 3](#toxics-08-00028-t003){ref-type="table"} reports the clinical and biological parameters recorded in our patients. SAPS II score and PSS were strongly predictive of severe outcome ([Figure 4](#toxics-08-00028-f004){ref-type="fig"}).

Therapeutic management included symptomatic measures as well as antidotes and life-support techniques. Mechanical ventilation was needed in 171 (58.8%) patients, catecholamines in 78 (26.8%) patients, renal replacement therapy in 32 (11%), and ECMO in three patients. Specific antidotes were used in 60 (20.6%) patients. [Table 4](#toxics-08-00028-t004){ref-type="table"} shows the therapeutics used in our patients.

5. Discussion {#sec5-toxics-08-00028}
=============

Our study provides information on the clinical and epidemiological characteristics of patients with severe acute poisoning in Martinique. It shows that the incidence rate of severe poisoning is high in this French overseas territory. Rates of intentional self-poisoning in Martinique were highest in males than in females. The common toxic agents recorded were chemical drugs, but also specific toxins that are forbidden according to European and French Law.

Acute poisonings are epidemic worldwide. They are a frequent reason for the consultation of emergency rooms \[[@B3-toxics-08-00028],[@B4-toxics-08-00028]\], represent 1--3% of all EDs visits, and account for 10% of all admissions for injuries \[[@B18-toxics-08-00028]\]. Annual hospital admissions for poisonings are about 260,000 in the USA and 80,000 in England \[[@B19-toxics-08-00028],[@B20-toxics-08-00028]\]. Overdoses account for one-fourth of all suicide attempts \[[@B20-toxics-08-00028]\]. In the USA, the rate of deaths from drug overdoses has increased from 4.4 per 100,000 population in 1999 to 14.7 in 2014 involving opioids \[[@B21-toxics-08-00028]\]. Admissions to ICU for drug overdoses vary from country to country and account for approximately 2.5--14% of poisoned patients \[[@B10-toxics-08-00028],[@B12-toxics-08-00028],[@B22-toxics-08-00028]\]. Our study including only severe patients showed an incidence rate of 7.7 severe cases/100,000 population. This public health problem can also be responsible for high mortality (10%) and disability in young people.

Victims of acute poisoning are typically young women with a history of psychiatric disorders \[[@B3-toxics-08-00028],[@B23-toxics-08-00028]\]. In our study, the mean age was 46 ± 19 years and 57% of patients were male. A history of psychiatric disorders was recorded in 50% of our patients. Our results showed that patients at risk in Martinique are young people with a predominance of males and people with previous psychiatric disorders. The majority of deaths were related to attempted suicide (86.5%) and the mean age of non-survivor patients was 56 ± 18 years. These data are slightly different from those of metropolitan France, where 65% of fatal poisonings are self-inflicted and the age group most represented is that of 30 to 59 years \[[@B1-toxics-08-00028]\]. The severity of cases in our study is evidenced by respiratory failure (59%), hemodynamic failure (27%), neurologic failure (45%), and renal failure (11%).

The prognosis of severely poisoned patients is generally favorable with a typically short ICU and hospital stay. Indeed, mortality rates in the ICU for poisoning admissions range from 1 to 6%, according to most reports \[[@B10-toxics-08-00028],[@B11-toxics-08-00028],[@B12-toxics-08-00028],[@B22-toxics-08-00028],[@B24-toxics-08-00028],[@B25-toxics-08-00028]\] and are significantly lower than that of the general ICU population \[[@B26-toxics-08-00028],[@B27-toxics-08-00028],[@B28-toxics-08-00028],[@B29-toxics-08-00028],[@B30-toxics-08-00028],[@B31-toxics-08-00028],[@B32-toxics-08-00028]\]. About 60% of the patients can leave the ICU within 24 h and only approximately 11% require critical care for longer than 48 h \[[@B7-toxics-08-00028],[@B33-toxics-08-00028],[@B34-toxics-08-00028]\]. In a Dutch study \[[@B25-toxics-08-00028]\], intoxications by opiates, cocaine, and amphetamine had the highest mortality two years after ICU admission (12.3%), whereas a combination of different intoxications had the lowest (6.3%). Additionally, mortality increases with age \[[@B25-toxics-08-00028],[@B35-toxics-08-00028]\].

In our study, mortality rate was 10.3%, the highest reported in the literature for other settings \[[@B10-toxics-08-00028],[@B11-toxics-08-00028],[@B12-toxics-08-00028],[@B22-toxics-08-00028],[@B24-toxics-08-00028],[@B25-toxics-08-00028]\]. Factors associated with severe outcomes were organ failure, metabolic acidosis, hypokalemia, hyperlactatemia, hypocalcemia, rhabdomyolysis, increased aspartate aminotransferases, and thrombocytopenia. These factors are commonly associated with death in critically ill patients in general. Age was higher in survivors. However, the Receiver operating characteristic curve analysis showed a low value of age to predict death in severely poisoned patients (AUC: 0.678), but the mortality rate was higher in patients greater than eighty years old.

Intoxications with ethanol or drugs are the most frequent causes in industrialized countries \[[@B23-toxics-08-00028],[@B36-toxics-08-00028],[@B37-toxics-08-00028],[@B38-toxics-08-00028],[@B39-toxics-08-00028]\]. In a Swedish study including 8155 intoxicated intensive care patients, the leading causes of admission were "mixed intoxications" (30%), intoxication to sedatives, hypnotics, and anticonvulsants (16%) and ethanol intoxication (15%) \[[@B39-toxics-08-00028]\]. In a French observational study including about 2500 patients, antidepressants, neuroleptics, benzodiazepines, and heart medication were the leading causes of intoxication-related ICU admission \[[@B23-toxics-08-00028]\]. However, in developing countries, intoxications with pesticides and organophosphates are important causes leading to ICU admission \[[@B34-toxics-08-00028],[@B40-toxics-08-00028]\].

In our study, the majority of serious poisonings and deaths were related to psychotropic and cardiotropic drugs ([Table 5](#toxics-08-00028-t005){ref-type="table"}). These data are comparable to those observed in metropolitan France and other industrialized countries \[[@B23-toxics-08-00028],[@B36-toxics-08-00028],[@B37-toxics-08-00028],[@B38-toxics-08-00028],[@B39-toxics-08-00028]\]; however, they can also be related to other toxic agents like pesticides. Indeed, in Martinique, severe toxicity and subsequent death can result from exposure to specific toxicants such as non-authorized drugs including industrial chemicals and herbicides (paraquat) or some local fruits and plants \[[@B41-toxics-08-00028],[@B42-toxics-08-00028]\]. Deaths secondary to pesticide poisoning represent 22%, comparable to the epidemiology reported from developing countries (23% of self-inflicted poisoning in Africa and 21% in South-East Asia) \[[@B20-toxics-08-00028]\]. Another herbicide causing severe intoxications and death in Martinique is Rubigine^®^, which accounted for 16% of all deaths in our study (slightly more than one-quarter of deaths due to non-medicinal drugs). Martinique consumes large quantities of pesticides (6 kg per capita of pesticides imported in 2002), mostly used in banana plantations. The use and storage of these pesticides by professionals, but also illegally by individuals, can lead to the occurrence of acute poisoning.

In our study, there was no serious accidental poisoning by pesticides or herbicides. Nor were there occupational poisonings. It may be concluded that the precautions or prohibitions relating to the use of these products are sufficiently respected in the agricultural setting in Martinique. Pesticide poisonings found in our study were mostly domestic. This implies that individuals still have access to these dangerous products, ordinarily accessible only to agricultural professionals, according to the decree of 26 February 2004 in France. Two products were most commonly found in our series: Aldicarb and Paraquat. Aldicarb is a carbamate insecticide that is the active substance in the pesticide Temik^®^. It was the most commonly used pesticide for severe poisoning in our study. It was prohibited by Prefectural decree in Martinique in 2002 and withdrawn from the market in 2004 at the national level. However, the product is still in circulation on the island either due to non-elimination and non-collection of existing stocks from agricultural professionals or because of the illegal acquisition of the product. This product is banned in France and the European Union, but is still available in certain regions of the world, particularly in the United States (where the final and total withdrawal of the product was scheduled for 2018) and in the Caribbean islands (the Dominican Republic and Saint Lucia in particular). In Martinique, it is used by the population as a rodenticide. Despite the frequency of severe poisoning by Temik^®^, there were no related deaths in our study.

In our study, only one patient presented with crack, and four with cocaine poisoning. However, the consumption of cocaine and more precisely crack cocaine is a public health problem in Martinique \[[@B43-toxics-08-00028]\]. The number of cases of severe poisoning was probably underestimated for several reasons, mainly the absence of systematic toxicological analysis and difficulties in the diagnosis. Indeed, in some cases, clinical signs were not specific and the history was poor.

Screening for the toxicant involved in severe poisoning is essential to guide specific therapeutics and to predict outcome. In our hospitals, the only available screenings are qualitative detection of tricyclic antidepressants, benzodiazepines, and barbiturates, and quantitative analysis of blood alcohol and acetaminophen concentrations. Pesticides/herbicides used in the West Indies for which screening tests are available (Cholinesterase test for Témik^®^, and dithionite test or blood concentration for paraquat) were not performed in our study. There were also no tests to investigate the presence of opiates, cannabis, and/or cocaine. Therefore, in our study, the diagnosis of acute poisonings was based on the history reported by the patient or their family and on the clinical manifestations and laboratory results. This underscores the underuse of the available toxicologic analysis in Martinique, which should be an integral part of the management.

Poisoning management includes symptomatic measures, organ support, and antidotes. In our study, 15% of patients received activated charcoal, 20% were treated with gastric lavage, and 21% received antidotes. The only treatment statistically associated with a favorable outcome was antidote administration. Indeed, the use of antidotes was systemic in pesticide/herbicide poisoning (atropine) and Rubigine^®^ intoxication (calcium gluconate) ([Table 5](#toxics-08-00028-t005){ref-type="table"}). N-acetylcysteine and vitamin K were used in all cases of paracetamol poisoning. The use of flumazenil is not routine in benzodiazepine poisoning, because in most cases, benzodiazepine poisonings are associated with multiple other toxicants. This can be explained by a characteristic clinical picture and the awareness of the seriousness of these types of poisoning.

Our study had several limitations because of its retrospective design and its focus on severe patients only. However, this is the first epidemiological report from French West Indies. It confirms the burden of poisonings as a neglected public health problem and the need for better investigation and understanding of this topic. This study highlights the need to develop a toxicovigilance system in the West Indies with a toxicovigilance system for several reasons. The incidence of poisoning in the West Indies is unknown. Moreover, there is no regional or interregional registry to identify poisonings and allowing descriptive analyses. A local facility would permit the collection of epidemiological and clinical information and provide better management and follow-up of the severely poisoned patients. This system would allow monitoring of the toxic effects of products currently available in our region, setting up warning and prevention measures, informing and training the public and health professionals, and sensitizing regional and interregional authorities on specific toxicants like illegal drugs, chlordecone, Rubigine^®^, Gramoxone^®^, some caustics, pesticides, local fruits (like starfruit \[[@B13-toxics-08-00028]\]), and some traditional plants ([Table 5](#toxics-08-00028-t005){ref-type="table"}). The dissemination of this information could be made through teaching and training campaigns coordinated by a Caribbean toxicovigilance system.

6. Conclusions {#sec6-toxics-08-00028}
==============

Due to its tropical climate, its geographic location in the Caribbean, which allows the country to be supplied with substances prohibited under French law, but also due to non-compliance with regulations regarding the disposal of product stocks, Martinique has particular characteristics in terms of the epidemiology of severe acute poisoning. As evidenced in this study, mortality is high despite appropriate management. There is, therefore, an urgent need to provide French West Indies with an Anti-Poison Center and local toxicovigilance facility. Prospective multicenter studies in the region are required to better understand the epidemiology of poisonings in the region. Clinicians should also be aware that severe toxicity can result from exposure to non-authorized industrial drugs as well as to environmental agents including plants, herbal, and traditional remedies.
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toxics-08-00028-t001_Table 1

###### 

The epidemiological characteristics and outcome of patients.

  Variable                  Total Population   Non Survivors   Survivors   *p*                              
  ------------------------- ------------------ --------------- ----------- ------------ ----- ------------- -------
  Age (years)               291                46 ± 19         30          56 ± 18      261   45 ± 18       0.001
  Male gender               291                166 (57%)       30          17 (56.7%)   261   149 (57.1%)   0.965
  Medical history                                                                                           
  Psychiatric disorder      287                143 (49.8%)     30          14 (46.7%)   257   129 (50.2%)   0.865
  Drug intoxication         284                65 (22.9%)      29          1 (3.4%)     255   64 (25.1%)    0.031
  Alcohol abuse             284                59 (20.8%)      29          6 (20.7%)    255   53 (20.8%)    0.940
  Hospitalization                                                                                           
  Emergency Department      287                185 (64.5%)     30          19 (63.3%)   257   166 (64.6%)   0.785
  Medical ward              288                26 (9%)         29          4 (13.8%)    259   22 (8.5%)     0.271
  Level 3 ICU               288                227 (78.8%)     30          23 (76.7%)   258   204 (79.1%)   0.802
  Level 2 ICU               290                71 (24.5%)      30          6 (20%)      260   65 (25%)      0.787
  Severity                                                                                                  
  PSS                       289                2.7 ± 0.8       30          4 ± 0        259   2.5 ± 0.7     0.000
  SAPS II                   191                39 ± 23         19          71 ± 19      172   36 ± 20       0.000
  Issue                                                                                                     
  Hospital Length of stay   290                6 ± 7           30          5 ± 8        260   6 ± 7         0.750
  1 day                     290                18 (6.2%)       30          8 (26.7%)    260   10 (3.8%)     \-
  2 to 7 days               290                225 (77.3%)     30          17 (56.7%)   260   208 (80%)     \-
  8 to 14 days              290                21 (7.2%)       30          3 (10%)      260   18 (6.9%)     \-
  \>15 days                 290                26 (8.9%)       30          2 (6.7%)     260   24 (9.2%)     \-
  Cardiac arrest            291                34 (11.7%)      30          30 (100%)    261   4 (1.5%)      0.000
  Death                     291                30 (10.3%)      30          30 (100%)    261   0 (0%)        \-

-: *p* value not calculated.

toxics-08-00028-t002_Table 2

###### 

Involved toxics in survivors and non survivors.

  Variable                                  Total Population   Non-Survivors   Survivors   *p*                              
  ----------------------------------------- ------------------ --------------- ----------- ------------ ----- ------------- -------
  Therapeutic drug intoxication             291                169 (58.1%)     30          11 (36.7%)   261   158 (60.5%)   0.012
  Nb of therapeutic drug involved           291                1.2 ± 1.3       30          0.6 ± 0.9    261   1.3 ± 1.3     0.090
  Antipsychotics                            291                116 (39.9%)     30          4 (13.3%)    261   112 (42.9%)   0.002
  Benzodiazepines                           291                76 (26.1%)      30          2 (6.7%)     261   74 (28.4%)    0.010
  Barbiturates                              291                3 (1%)          30          0 (0%)       261   3 (1.1%)      0.555
  Neuroleptics                              291                33 (11.3%)      30          1 (3.3%)     261   32 (12.3%)    0.144
  Lithium                                   291                4 (1.4%)        30          0 (0%)       261   4 (1.5%)      0.495
  Tricyclic antidepressants                 291                18 (6.2%)       30          1 (3.3%)     261   17 (6.5%)     0.493
  Carbamate                                 291                4 (1.4%)        30          0 (0%)       261   4 (1.5%)      0.495
  Cardiotrops                               291                26 (8.9%)       30          3 (10%)      261   23 (8.8%)     0.829
  Antiarrhythmics                           291                3 (1%)          30          0 (0%)       261   3 (1.1%)      0.555
  Β-Blockers                                291                10 (3.4%)       30          2 (6.7%)     261   8 (3.1%)      0.305
  Calcium inhibitors                        291                7 (2.4%)        30          1 (3.3%)     261   6 (2.3%)      0.726
  Analgesics                                291                16 (5.5%)       30          1 (3.3%)     261   15 (5.7%)     0.583
  Paracetamol                               291                15 (5.2%)       30          1 (3.3%)     261   14 (5.4%)     0.634
  Chloroquine                               291                1 (0.3%)        30          0 (0%)       261   1 (0.4%)      0.734
  Insulin                                   291                3 (1%)          30          0 (0%)       261   3 (1.1%)      0.555
  Other therapeutic drugs                   291                17 (5.8%)       30          3 (10%)      261   14 (5.4%)     0.305
  Chemical intoxication                     291                152 (52.2%)     30          19 (63.3%)   261   133 (51%)     0.199
  Nb of chemical products involved          291                0.8 ± 0.9       30          0.9 ± 0.9    261   0.7 ± 0.9     0.250
  Herbicides                                291                29 (10%)        30          6 (20%)      261   23 (8.8%)     0.053
  Aldicarb                                  291                23 (7.9%)       30          0 (0%)       261   23 (8.8%)     0.090
  Organophosphorus                          291                22 (7.6%)       30          2 (6.7%)     261   20 (7.7%)     0.845
  Gramoxone                                 291                6 (2.1%)        30          5 (16.7%)    261   1 (0.4%)      0.000
  Chloralose                                291                8 (2.7%)        30          0 (0%)       261   8 (3.1%)      0.331
  Rubigine^®^                               291                28 (9.6%)       30          4 (13.3%)    261   24 (9.2%)     0.467
  Caustics                                  291                23 (7.9%)       30          1 (3.3%)     261   22 (8.4%)     0.327
  Ethylene glycol                           291                2 (0.7%)        30          0 (0%)       261   2 (0.8%)      0.630
  Formaldehyde                              291                1 (0.3%)        30          1 (3.3%)     261   0 (0%)        0.003
  Crack cocaine                             291                1 (0.3%)        30          0 (0%)       261   1 (0.4%)      0.734
  Cocaine                                   291                4 (1.4%)        30          1 (3.3%)     261   3 (1.1%)      0.331
  Cannabis                                  291                4 (1.4%)        30          0 (0%)       261   4 (1.5%)      0.495
  OH3                                       291                56 (19.2%)      30          5 (16.7%)    261   51 (19.5%)    0.705
  Fruits                                    291                5 (1.7%)        30          2 (6.7%)     261   3 (1.1%)      0.028
  Ciguatoxine                               291                1 (0.3%)        30          0 (0%)       261   1 (0.4%)      0.734
  Mixed therapeutic and chemical toxic      291                30 (10.3%)      30          0 (0%)       261   30 (11.5%)    0.050
  Nb of toxicant involved                   291                1.1 ± 0.3       30          1 ± 0        261   1.1 ± 0.3     0.005
  Multiple therapeutic drugs intoxication   169                61 (36.1%)      11          2 (18.2%)    158   59 (37.3%)    0.025
  Multiple chemical intoxication            152                48 (31.6%)      19          7 (36.8%)    133   41 (30.8%)    0.371
  Drug overdose                             291                37 (12.7%)      30          7 (23.3%)    261   30 (11.5%)    0.065
  Intentional self-poisoning                289                250 (86.5%)     30          24 (80%)     259   226 (87.3%)   0.484

toxics-08-00028-t003_Table 3

###### 

Clinical and biological parameters recorded in our patients.

  Parameter                                  Normal Range   Total Population   Non Survivors     Survivors   *p*                                       
  ------------------------------------------ -------------- ------------------ ----------------- ----------- ----------------- ----- ----------------- -------
  Temperature (°C)                           36.1--37.5     74                 36.6 ± 1.6        11          36.2 ± 2.3        63    36.7 ± 1.4        0.361
  Breath rhythm (breath/min)                 16--20         50                 25 ± 19           9           44 ± 37           41    21 ± 7            0.000
  SaO~2~ (%)                                 92--100        94                 94 ± 9            10          90 ± 10           84    94 ± 9            0.099
  Cardiac rhythm (beat/min)                  60--90         179                89 ± 28           23          85 ± 30           156   90 ± 28           0.472
  Shock                                      \-             291                78 (26.8%)        30          28 (93.3%)        261   50 (19.2%)        0.000
  Ventricular fibrillation or tachycardia    \-             291                8 (2.7%)          30          7 (23.3%)         261   1 (0.4%)          0.000
  GCS                                        15             227                9 ± 4             21          9 ± 5             206   8 ± 4             0.860
  Seizures                                   \-             291                31 (10.7%)        30          5 (16.7%)         261   26 (10%)          0.260
  Myoclonus                                  \-             291                28 (9.6%)         30          1 (3.3%)          261   27 (10.3%)        0.217
  Gastro-intestinal disorders                \-             291                78 (26.8%)        30          14 (46.7%)        261   64 (24.5%)        0.010
  Pneumonia                                  \-             291                49 (16.8%)        30          7 (23.3%)         261   42 (16.1%)        0.315
  Conjunctivitis                             \-             291                3 (1%)            30          0 (0%)            261   3 (1.1%)          0.555
  Other infections                           \-             291                77 (26.5%)        30          10 (33.3%)        261   67 (25.7%)        0.173
  Biology                                                                                                                                              
  pH                                         7.40 ± 0.02    81                 7.30 ± 0.20       17          7.20 ± 0.20       64    7.30 ± 0.20       0.092
  Alkaline reserve (mmol/L)                  22--29         66                 19.3 ± 7.1        13          15.2 ± 6.3        53    20.3 ± 7          0.019
  PaCO~2~ (mmHg)                             35--45         68                 39.8 ± 15         10          40.5 ± 18.8       58    39.6 ± 14.4       0.867
  Lactate (mmol/L)                           0.5--2.2       53                 6.4 ± 5.9         9           11.1 ± 7.7        44    5.4 ± 5           0.006
  Hyper lactacidemia                         \-             53                 37 (69.8%)        9           8 (88.9%)         44    29 (65.9%)        0.171
  Sodium (mmol/L)                            136--145       59                 139 ± 8           8           136 ± 9           51    139 ± 7           0.225
  Potassium (mmol/L)                         3.5--5.1       82                 4 ± 1.3           12          5.4 ± 1.5         70    3.8 ± 1.1         0.000
  Hypokalemia                                \-             82                 26 (31.7%)        12          1 (8.3%)          70    25 (35.7%)        0.029
  Hyperkalemia                               \-             82                 13 (15.9%)        12          7 (58.3%)         70    6 (8.6%)          0.000
  Calcium (mmol/L)                           2.15--2.55     33                 2.1 ± 0.4         2           1.4 ± 0.2         31    2.1 ± 0.4         0.029
  Magnesium (mmol/L)                         0.75--0.90     10                 0.9 ± 0.2         2           0.8 ± 0.1         8     0.9 ± 0.3         0.497
  Phosphorus (mmol/L)                        0.80--1.35     22                 1.1 ± 0.6         1           1.27              21    1.1 ± 0.6         0.805
  Creatinine (µmol/L)                        62--106        90                 220 ± 213         15          270 ± 179         75    210 ± 219         0.317
  Urea nitrogen (mmol/L)                     1.7--8.3       73                 15 ± 34           10          43 ± 87.8         63    10.6 ± 8.9        0.004
  Creatine Kinase (IU/L)                     38--174        34                 15,974 ± 45,164   5           38,193 ± 44,310   29    12,143 ± 44,947   0.000
  Rhabdomyolysis                             \-             34                 20 (58.8%)        5           5 (100%)          29    15 (51.7%)        0.041
  Troponins (µg/L)                           0--0.014       15                 0.8 ± 1.9         4           0.5 ± 0.6         11    0.9 ± 2.2         0.700
  Elevated troponins                         \-             3                  3 (100%)          1           1 (100%)          2     2 (100%)          0.187
  Glycaemia (mmol/L)                         3.9--7.1       12                 8.3 ± 5.1         2           4.6 ± 6           10    9.1 ± 4.9         0.270
  Aspartate aminotransferases (AST) (IU/L)   \<37           43                 1968 ± 3894       6           5452 ± 4317       37    1403 ± 3570       0.042
  Alanine aminotransferases (ALT) (IU/L)     \<40           43                 961 ± 2211        6           2431 ± 2574       37    723 ± 2089        0.239
  Platelet count (Giga/L)                    150--400       29                 152 ± 95          7           75 ± 74           22    177 ± 88          0.010
  Prothrombine time (%)                      60--100        38                 42 ± 31           8           31 ± 18           30    45 ± 34           0.262
  SvO~2~ (%)                                 75--85         2                  82 ± 4.2          1           85                1     79                \-
  Toxicologic analysis                       \-             284                111 (39.1%)       30          8 (26.7%)         254   103 (40.6%)       0.218

-: Non appropriate.

toxics-08-00028-t004_Table 4

###### 

Therapeutic management of our patients.

  Parameter                   Total Population   Non Survivors   Survivors   *p*                              
  --------------------------- ------------------ --------------- ----------- ------------ ----- ------------- -------
  Activated charcoal          291                44 (15.1%)      30          2 (6.7%)     261   42 (16.1%)    0.172
  Gastric lavage              291                57 (19.6%)      30          8 (26.7%)    261   49 (18.8%)    0.302
  Antidotes                   291                60 (20.6%)      30          2 (6.7%)     261   58 (22.2%)    0.046
  Mechanical ventilation      291                171 (58.8%)     30          29 (96.7%)   261   142 (54.4%)   0.000
  ARDS                        172                12 (7%)         30          6 (20%)      142   6 (4.2%)      0.000
  MV duration (days)          171                6 ± 8           29          5 ± 8        142   6 ± 8         0.433
  Catecholamines              291                78 (26.8%)      30          28 (93.3%)   261   50 (19.2%)    0.000
  Renal replacement therapy   291                32 (11%)        30          13 (43.3%)   261   19 (7.3%)     0.000
  ECMO                        291                3 (1%)          30          2 (6.7%)     261   1 (0.4%)      0.001
  Treatment                   291                133 (45.7%)     30          20 (66.7%)   261   113 (43.3%)   0.015
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###### 

Features of the main involved toxicants with a focus on those more rarely observed in Western countries.

  ----------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------
  **Main Toxicants Involved**                     **Related Clinical and Biological Features**                                                                                                                                          

  Benzodiazepines                                 Coma, aspiration pneumonia                                                                                                                                                            

  Neuroleptics                                    Coma, respiratory failure, shock, aspiration pneumonia, renal failure, rhabdomyolysis                                                                                                 

  Cardiotrops                                     Cardiac arrhythmias, shock, heart conduction dysfunction, cardiac arrest, renal failure, elevation in lactate, rhabdomyolysis, liver failure                                          

  Tricyclic antidepressants                       Coma, seizures, shock, heart conduction dysfunction, aspiration pneumonia, renal failure, rhabdomyolysis                                                                              

  **The Rarest Toxicants in Western Countries**   **Specific Features**                                                                                                                                                                 **Specific Management**

  Herbicides, paraquat                            Respiratory failure\                                                                                                                                                                  No effective antidote
                                                  (acute respiratory distress syndrome), elevation in transaminase, renal failure                                                                                                       

  Rubigine^®^ (Hydrofluoric acid)                 Gastrointestinal disturbances (corrosion), dermal injuries, hypocalcemia, metabolic acidosis, respiratory failure, seizures, dysrhythmias, cardiovascular disorders, cardiac arrest   Calcium gluconate, analgesics, hemodialysis,

  Pesticides Organophosphates                     Excessive respiratory secretions, and bronchoconstriction, bradycardia, myosis, neuromuscular weakness, seizures, coma, cardiovascular collapse                                       Atropine, pralidoxime, diazepam

  Star Fruit (Carambola)\                         Hiccups, vomiting, encephalopathy, seizures, neuropsychiatric manifestations, acute kidney injury and chronic kidney disease\                                                         No effective antidote\
  (Toxin: oxalic acid)                            Renal histology: oxalate crystals obstructing the tubules                                                                                                                             Renal replacement therapy (hemodialysis or hemoperfusion)
  ----------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------
